Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oxycodone/promethazine - Charleston Laboratories

Next Previous
Drug Profile

Oxycodone/promethazine - Charleston Laboratories

Alternative Names: CLOX-315; Promethazine/oxycodone

Latest Information Update: 23 Mar 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Charleston Laboratories
  • Class Alkaloids; Antiemetics; Hypnosedatives; Morphine derivatives; Opioid analgesics; Propylamines; Sedating antihistamines; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists; Muscarinic receptor antagonists; Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists; Serotonin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Acute pain
  • Discontinued Nausea and vomiting

Most Recent Events

  • 23 Mar 2021 Oxycodone/promethazine is still in phase III trials for Acute pain in USA (PO) (Charleston Laboratories pipeline, March 2021)
  • 23 Mar 2021 Discontinued - Phase-III for Nausea and vomiting (Prevention) in USA (PO) (Charleston Laboratories pipeline, March 2021)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top